Octapharma
Clinical trials sponsored by Octapharma, explained in plain language.
-
New hope for toddlers with rare bleeding disorder: wilate shows promise in preventing bleeds
Disease control CompletedThis study tested a medicine called wilate in 12 children under 6 years old with severe von Willebrand disease, a bleeding disorder. The goal was to see if regular infusions of wilate could prevent bleeding episodes over a year. The study measured how many bleeds occurred, how th…
Phase: PHASE3 • Sponsor: Octapharma • Aim: Disease control
Last updated May 17, 2026 09:08 UTC
-
New antibody treatment may shield leukemia patients from deadly infections
Disease control CompletedThis study tested whether Panzyga, an antibody treatment, can prevent serious infections in people with chronic lymphocytic leukemia (CLL) who also have low antibody levels. About 247 adults with CLL received either Panzyga or a placebo. The goal was to see if Panzyga reduces maj…
Phase: PHASE3 • Sponsor: Octapharma • Aim: Disease control
Last updated May 14, 2026 12:03 UTC
-
Could an IV drug ease sudden OCD in kids? new study tests panzyga
Disease control CompletedThis study tested whether Panzyga, a medicine given through a vein, can reduce obsessive-compulsive symptoms in children aged 6 to 17 with PANS/PANDAS. The trial compared Panzyga to a placebo over 9 weeks. The main goal was to see if symptoms improved more with Panzyga than with …
Phase: PHASE3 • Sponsor: Octapharma • Aim: Disease control
Last updated May 07, 2026 18:39 UTC